Pharmacokinetics of low molecular weight dermatan sulphate (desmin) in different cohorts of patients.
Saivin
S
S
Laboratoire de Pharmacocinétique et Toxicologie Clinique, Hôpital Rangueil, Toulouse, France.
Carrie
D
D
Escourrou
J
J
Duchene
P
P
Zamboni
V
V
Barbanti
M
M
Palazzini
E
E
Houin
G
G
D000074:Acenocoumarol / Q000627:therapeutic use; D000328:Adult; D002779:Cholestasis / Q000209:etiology / Q000378:metabolism; D002863:Chromogenic Compounds; D015331:Cohort Studies; D003893:Desmin / Q000009:adverse effects / Q000032:analysis / Q000493:pharmacokinetics*; D015951:Factor Xa / Q000032:analysis; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000378:metabolism; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D010437:Peptic Ulcer / Q000378:metabolism; D011516:Prothrombin / Q000032:analysis; D013918:Thrombin Time; D013927:Thrombosis / Q000188:drug therapy / Q000378:metabolism
D002863:Chromogenic Compounds; D003893:Desmin; D011516:Prothrombin; C025337:Factor IIa; D015951:Factor Xa; D000074:Acenocoumarol